Cognitive Impairment in Neurodegenerative Movement Disorders.

Carla Abdelnour, Kathleen L Poston

Journal: Seminars in neurology 2023;43(1):81-94

PMID: 36940727

Abstract

Patients with neurodegenerative movement disorders can develop cognitive impairment during the disease. Cognitive symptoms have been associated with decreased quality of life, higher caregiver burden, and earlier institutionalization, and are therefore critical for physicians to understand and address. The evaluation of cognitive performance of patients with neurodegenerative movement disorders is important for providing adequate diagnosis, management, prognosis, and support patients and their caregivers. In this review, we discuss the features of the cognitive impairment profile of commonly encountered movement disorders: Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome, and Huntington's disease. In addition, we provide neurologists with practical guidance and evaluation tools for the assessment and management of these challenging patients.

Thieme. All rights reserved.

Address: Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.